Effects of erythropoietin and pentoxifylline on the oxidant and antioxidant systems in the experimental short bowel syndrome

Cell Biochemistry and Function

Volumn 21, Issue 1, 2003, Pages 49-54

  Noyan, Tevfik ^a   Önem, Önder ^a   Şekeroǧlu, M Ramazan ^a   Köseoǧlu, Burhan ^a   Dülger, Haluk ^a   Bayram, Irfan ^a   Yalčinkaya, A Sadik ^a   Bakan, Vedat ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Erythropoietin; Pentoxifylline; Short bowel syndrome; Surgerical stress

Indexed keywords

ANTIOXIDANT; ERYTHROPOIETIN; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OXIDIZING AGENT; OXYGEN RADICAL; PENTOXIFYLLINE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; ILEUM; INTESTINE CRYPT; INTESTINE MUCOSA; INTESTINE VILLUS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SHORT BOWEL SYNDROME; SMALL INTESTINE RESECTION; SURGICAL STRESS; THICKNESS;

ANIMALS; ANTIOXIDANTS; ERYTHROPOIETIN; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; ILEUM; MALE; MALONDIALDEHYDE; OXIDANTS; PENTOXIFYLLINE; RATS; RATS, SPRAGUE-DAWLEY; SHORT BOWEL SYNDROME; SUPEROXIDE DISMUTASE;

ANIMALIA;

EID: 0037370852     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.991     Document Type: Article

References (44)

1. Shanbhogue LKR, Molenaar JC. Short Bowel Syndrome. Br J Surg 1994; 81: 486-499.
2. Rowe MI, O'Nell JA, Grosfeld JL, Fonkalsrud EW, Coran AG. Essentials of Paediatric Surgery (1st edn). Mosby: St. Louis, Missouri, 1995.
3. Ebert BL, Bunn HF. Regulation of the erythropoietin gene. Blood 1999; 94: 1864-1877.
4. Ledbetter DJ, Juul SE. Erythropoietin and incidence of narcotising enterocolitis in infants with very low birth weight. J Pediatr Surg 2000; 35: 178-182.
5. Fatouros MS, Vekinis G, Bourantas KL, et al. Influence of growth factors, erythropoietin and granulocyte macrophage colony stimulating factor on mechanical strength and healing of colonic anastomoses in rats. Eur J Surg 1999; 165: 986-992
6. Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34: 50-97.
7. Chapelier A, Reigner J, Mazmanian M, et al. Pentoxifylline and lung ischaemia-reperfusion injury: application to lung transplantation. Universite Paris-Sud Lung Transplant Group. J Cardiovasc Pharmacol 1995; 25(Suppl. 2): 130-133.
8. Sener G, Akgün U, Satiroǧlu H, Topaloǧlu U, Keyer-Uysal M. The effect of pentoxifylline on intestinal ischaemia-reperfusion injury. Blackwell Sci Fun & Clin Pharmacol 2001; 15: 19-22.
9. Mustafa NA, Yandi M, Albayrak L, Yildiz K. Effect of pentoxifylline on the ischaemia-reperfusion injury of the intestine. Int Surg 1995; 80: 152-155.
10. Savas C, Aras T, Cakmak M, et al. Pentoxifylline inhibits overflow and reduces intestinal reperfusion injury. J Pediatr Surg 1997; 32: 905-910.
11. Pompella A, Maellora E, Casini AF, Ferrali M, Ciccoli L, Comporti M. Measurement of lipid peroxidation in vivo: a comparison of different procedures. Lipids 1987; 212: 206-211.
12. Guemouri L, Arthur Y, Herbeth B. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991; 38: 1539-1543.
13. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989; 179: 8-18.
14. Paglia DE, Valentine WN. Studies on the quantitative and quantitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-168.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin-phenol reagent. J Biol Chem 1951; 193: 265-275.
16. Wolf SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Rad Biol Med 1991; 10: 339-352.
17. Niwa Y, Kasama T, Miyachi Y, Kanoh T. Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging. Life Sci 1989; 44: 1655-1664.
18. Yagi K. Increased lipid peroxides iniate atherogenesis. Bio Essays 1984; 1: 58-60.
19. Nishigaki I, Hagihara M, Hiramatsu M, Izawa Y, Yagi K. Effect of thermal injury on lipid peroxide levels of rat. Biochem Med 1980; 24: 185-189.
20. Akkus I, Kalak S, Vural H, et al. Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type 2 diabetes mellitus. Clin Chim Acta 1996; 244: 221-227.
21. Sekeroglu MR, Sahin H, Dülger H, Algün E. The effect of dietary treatment on erythrocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase, and serum lipid peroxidation in patients with type 2 diabetes mellitus. Clin Biochem 2000; 33: 669-674.
22. Tourel DB, Guerin MC, Torreilles J. Is malondialdehyde a valuable indicator of lipid peroxidation? Biochem Pharmacol 1992; 44: 985-988.
23. Draper HH, McGirr LG, Hadley M. The metabolism of malondialdehyde. Lipids 1986; 21: 305-307.
24. Skjeldal S, Hvaal K, Nordsletten L, Aesen AO, Reikeras O, Tarvik A. Pentoxifylline reduces skelatal muscle necrosis after acute hind limb ischaemia in rats. Eur Surg Res 1994; 26: 94-100.
25. Parks DA. Oxygen radicals: mediators of gastrointestinal patho-physiology. Gut 1989; 30: 293-298.
26. Parks DA, Bulkley GB, Granger DN. Role of oxygen derived free radicals in digestive tract diseases. Surgery 1983; 94: 415- 422.
27. Dalsing MC, Grosfeld JL, Shiffler MA, et al. Superoxide dismutase: a cellular proctective enzyme in bowel ischaemia. J Surg Res 1983; 34: 589-596.
28. Schoenberg MH, Beger HG. Oxygen radicals and postischemic organ damage - pathophysiology, clinical relevance and therapy. Zentralbl Chir 1995; 120: 174-185.
29. Schoenberg MH, Beger HG. Reperfusion injury after intestinal ischaemia Crit Care Med 1993; 21: 1376-1386.
30. Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischaemia. Gastroenterology 1981; 81: 22-29.
31. Grisham MB, Hernandez LA, Granger DN, Xanthine oxidase and neutrophil infiltration in intestinal ischaemia. Am J Physiol 1986; 251: 567-574.
32. Hiramatsu K, Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridaemia and diabetes. Diabetes 1988; 37: 832-837.
33. Ramasarma T. Generation of hydrogen peroxide in biomembranes. Biochim Biophys Acta 1982; 694: 69-93.
34. Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996; 76: 839-885.
35. Krantz SB. Erythropoietin. Blood 1991; 77: 419-434.
36. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992; 72: 449-489.
37. Youssoufian H, Longmore G, Neumann D, Yoshimura A, Lodish HF. Structure, function, and activation of the erythropoietin receptor. Blood 1993; 81: 2223-2236.
38. McMien MA, Hurbial M, Sumpio B. Common pathway of endothelial-leukocyte interaction in shock, ischaemia and reperfusion. Am J Surg 1993; 166: 557-562.
39. Bradbury AW, Murie JA, Ruckley CV. Role of the leukocyte in the pathogenesis of vascular disease. Br J Surg 1993; 80: 1503-1512.
40. Flynn WJ, Cryer HG, Garrison RN. Pentoxifylline restores intestinal microvascular blood flow during resuscicated hemorrhagic shock. Surgery 1991; 110: 350-356.
41. Mandel GL. ARDS, neutrophils and pentoxifylline. Am Rev Respir Dis 1988; 138: 1103-1105.
42. Hillegass LM, Griswold DE, Brickson B, Albrightson-Winslow C. Assessment of myeloperoxidase in whole rat kidney. J Pharmacol Method 1990; 24: 285-295.
43. Beutler E. Red Blood Cell Metabolism. A Manual of Biochemical Methods (2nd edn). Grune Struttan, New York, USA, 1975; 112-114.
44. Siegers CP, Riemann D, Thies E, Younes M. Glutathione and GSH-dependent enzymes in the gastrointestinal mucosa of the rat. Cancer Lett 1988; 40: 71-76.